Kızılırmak, P. Et Al. 2022. Lipid Modification to Reduce Cardiovascular Risk in Secondary Prevention Patients with Special Emphasis on PCSK9 Inhibitor Requirement: An Analysis Based on Delphi Panel Approach.. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir , vol.50, no.8 , 554-560.

Kızılırmak, P., Öngen, Z., Güleç, S., Kayıkçıoğlu, M., Kılıçkap, M., Abacı, A., ... Özer, N.(2022). Lipid Modification to Reduce Cardiovascular Risk in Secondary Prevention Patients with Special Emphasis on PCSK9 Inhibitor Requirement: An Analysis Based on Delphi Panel Approach.. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir , vol.50, no.8, 554-560.

Kızılırmak, Pınar Et Al. "Lipid Modification to Reduce Cardiovascular Risk in Secondary Prevention Patients with Special Emphasis on PCSK9 Inhibitor Requirement: An Analysis Based on Delphi Panel Approach.," Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir , vol.50, no.8, 554-560, 2022

Kızılırmak, Pınar Et Al. "Lipid Modification to Reduce Cardiovascular Risk in Secondary Prevention Patients with Special Emphasis on PCSK9 Inhibitor Requirement: An Analysis Based on Delphi Panel Approach.." Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir , vol.50, no.8, pp.554-560, 2022

Kızılırmak, P. Et Al. (2022) . "Lipid Modification to Reduce Cardiovascular Risk in Secondary Prevention Patients with Special Emphasis on PCSK9 Inhibitor Requirement: An Analysis Based on Delphi Panel Approach.." Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir , vol.50, no.8, pp.554-560.

@article{article, author={Pınar Kızılırmak Et Al. }, title={Lipid Modification to Reduce Cardiovascular Risk in Secondary Prevention Patients with Special Emphasis on PCSK9 Inhibitor Requirement: An Analysis Based on Delphi Panel Approach.}, journal={Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir}, year=2022, pages={554-560} }